Australian Clinical Labs Limited

ASX ACL.AX

Australian Clinical Labs Limited Share Price on January 14, 2025: USD 2.14

Australian Clinical Labs Limited Share Price is USD 2.14 on January 14, 2025, a 8.65% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Australian Clinical Labs Limited 52-week high Share Price is USD 2.59 on October 01, 2024, which is 21.13% above the current Share Price.
  • Australian Clinical Labs Limited 52-week low Share Price is USD 1.44 on May 28, 2024, which is -32.95% below the current Share Price.
  • Australian Clinical Labs Limited average Share Price for the last 52 weeks is USD 1.96.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
ASX: ACL.AX

Australian Clinical Labs Limited

CEO Ms. Melinda McGrath
IPO Date May 14, 2021
Location Australia
Headquarters 1868-1892 Dandenong Road
Employees 4,900
Sector Health Care
Industries
Description

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Similar companies

HLS.AX

Healius Limited

USD 0.87

0.96%

StockViz Staff

January 15, 2025

Any question? Send us an email